Condition
Neurogenic Bladder Dysfunction Nos
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00711087Phase 2TerminatedPrimary
Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)
NCT03280186Not ApplicableUnknown
Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention
NCT01389921Not ApplicableCompleted
Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary Tract
NCT01523743Phase 4CompletedPrimary
Quality of Life Intermittent Catheter Study
Showing all 4 trials